IWC
DAWN

Integrated Wealth Concepts’s Day One Biopharmaceuticals DAWN Stock Holding History

Integrated Wealth Concepts’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$409K Buy
+19,088
New +$269K ﹤0.01% 1662
2025
Q4 		– Sell
-17,430
Closed -$123K – 1716
2025
Q3 		$123K Sell
17,430
-2,740
-14% -$18.9K ﹤0.01% 1905
2025
Q2 		$131K Buy
20,170
+3,032
+18% +$20.9K ﹤0.01% 1808
2025
Q1 		$136K Sell
17,138
-136
-0.8% -$1.47K ﹤0.01% 1657
2024
Q4 		$219K Buy
+17,274
New +$240K ﹤0.01% 1550

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Integrated Wealth Concepts's DAWN Position: Q1 2026 in Review

Integrated Wealth Concepts opened a new position in Day One Biopharmaceuticals (DAWN) in Q1 2026: 19,088 shares worth $409K. The stake represents ﹤0.01% of the portfolio and ranks #1662 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in DAWN as recently as Q3 2025.

Integrated Wealth Concepts first reported a position in DAWN in Q4 2024 and has held it in 5 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Integrated Wealth Concepts held 19,088 shares of Day One Biopharmaceuticals worth $409K as of Q1 2026.
  • Day One Biopharmaceuticals was a new Integrated Wealth Concepts position in Q1 2026.
  • Day One Biopharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #1662 holding.
  • Integrated Wealth Concepts first reported a position in Day One Biopharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.